查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
发作性睡病治疗市场，按类型、产品、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1419095

发作性睡病治疗市场，按类型、产品、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Narcolepsy Therapeutics Market, By Type, By Product, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，发作性睡病治疗市场规模为 34.3 亿美元，2023 年至 2030 年复合CAGR为 8.34%。

发作性睡病治疗市场-市场动态

睡眠障碍盛行率的增加、研发活动和投资的增加将推动市场需求

研发支出和活动的增加、疾病盛行率的上升以及创新药品的推出是推动市场扩张的一些主要原因。根据美国国家神经疾病和中风研究所 (NINDS) 的估计，发作性睡病影响美国 135,000 至 20 万人。在未来几年中，被诊断为发作性睡病的人数可能会增加，因为这种疾病在承受较高压力的人中更为常见。在预测期内，推动市场扩张的关键驱动力之一是患者基础的增加。根据国家罕见疾病组织的数据，大约每 2,000 人中就有 1 人患有这种疾病。同样，美国神经病学会的研究发现，每 10 万人中患病率从 20 到 60 不等。

由于为治疗疾病引入新的治疗解决方案的研发 (R&D) 努力不断增加，该市场不断增长。由于最近研究和开发活动的加速，新的治疗替代方案将在未来几年推出。例如，2021年5月，武田药品工业株式会社宣布研发针对发作性睡病的药物。

发作性睡病治疗市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 8.34% 左右的CAGR成长
  • 根据类型细分，由于 WAKIX、Xyrem、Xywav 等新型药物的广泛采用，预计猝倒症细分市场将在 2022 年显示最大的市场份额。
  • 根据产品细分，羟丁酸钠是 2022 年的领先细分市场，主要是由于诊断意识程度不断提高。
  • 从地区来看，北美是 2022 年的主要收入来源。亚太地区预计在预测期内以最快的 CAGE 成长。

发作性睡病治疗市场区隔分析：

全球发作性睡病治疗市场根据类型、产品和地区进行细分。

市场依类型分为两类：猝倒型和无猝倒型。猝倒症细分市场占据主导地位。作为患者主要症状的猝倒盛行率的上升正在推动该细分市场的成长。

市场依产品分为三类：中枢神经系统兴奋剂、羟丁酸钠和三环抗忧郁剂。氧丁酸钠细分市场在市场上占据主导地位，并可能在预测期内保持其主导地位。预计针对罕见神经系统疾病患者的中枢神经系统兴奋剂的研发工作不断增加将推动该领域的成长。

发作性睡病治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

发作性睡病治疗市场-竞争格局：

发作性睡病治疗市场本质上较不分散，很少有参与者主导全球市场。市场主要参与者专注于新产品设计以及快速投资和併购。例如，2022年5月，Axsome Therapeutics, Inc.宣布在美国市场从Jazz Pharmaceuticals收购Sunosi。

最近的发展：

2023 年 5 月，Avadel Pharmaceuticals 的治疗发作性睡病药物 Lumryz 获得美国 FDA 最终批准。

2022 年 1 月，美国 FDA 核准 Jazz Pharmaceuticals 的 Xywav 取得孤儿药独占权，用于治疗成人特发性嗜睡症。

目录

第一章：发作性睡病治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 发作性睡病治疗市场片段（按类型）
    • 发作性睡病治疗市场片段（按产品）
    • 发作性睡病治疗市场片段（按国家/地区）
    • 按地区分類的发作性睡病治疗市场片段
  • 竞争洞察

第 3 章：发作性睡病治疗主要市场趋势

  • 发作性睡病治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 发作性睡病治疗市场限制
    • 市场限制影响分析
  • 发作性睡病治疗市场机会
  • 发作性睡病治疗市场未来趋势

第 4 章：发作性睡病治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：发作性睡病治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：发作性睡病治疗市场格局

  • 2022 年发作性睡病治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：嗜睡症治疗市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 猝倒症
    • 没有猝倒

第 8 章：嗜睡症治疗市场 - 副产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 中枢神经系统兴奋剂
    • 羟丁酸钠
    • 三环抗忧郁剂。

第 9 章：发作性睡病治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美发作性睡病治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按产品）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲发作性睡病治疗药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按产品）
    • 德国
    • 义大利
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区发作性睡病治疗药物主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按产品）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲发作性睡病治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按产品）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲发作性睡病治疗药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按产品）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 嗜睡症治疗产业

  • 竞争仪表板
  • 公司简介
    • Teva Pharmaceutical Industries Ltd.
    • Avadel Pharmaceuticals
    • Jazz Pharmaceuticals, Inc.
    • Takeda Pharmaceutical Company
    • Harmony Biosciences
    • Novartis AG
    • Rhodes Pharmaceuticals LP
    • Axsome Therapeutics, Inc.
    • Janssen Global Services, LLC
    • Ligand Pharmaceuticals Incorporated
    • Shionogi Inc.
    • Eli Lilly and Company
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2160

REPORT HIGHLIGHT

Narcolepsy Therapeutics Market size was valued at USD 3,430 Million in 2022, expanding at a CAGR of 8.34% from 2023 to 2030.

A lifelong sleep illness that causes uncontrollably sudden episodes of extreme sleepiness called as narcolepsy which impacts all facets of a patient's life and makes daily tasks challenging. Narcolepsy can be treated symptomatically with medications that promote wakefulness and raise dopamine release at the presynaptic level.

Narcolepsy Therapeutics Market- Market Dynamics

Increasing prevalence of sleep disorder, increasing R&D activities & investments is to propel market demand

Increasing R&D expenditures and activities, rising disease prevalence, and the launch of innovative medicinal goods are some of the main causes propelling market expansion. Narcolepsy affects between 135,000 and 200,000 people in the United States, according to estimates from the National Institute of Neurological Disorders and Stroke (NINDS). In the upcoming years, there will likely be a rise in the number of people with narcolepsy diagnoses because the disease is more common in those who experience higher levels of stress. Over the forecast period, one of the key drivers propelling the market expansion is an increase in the patient base. As per the National Organization for Rare Disorders, around 1 in 2,000 individuals are affected with the condition. In a similar vein, the American Academy of Neurology study found that the prevalence of disease varies from 20 to 60 in 100,000 people.

The market is growing because of an increase in research and development (R&D) efforts to introduce novel therapeutic solutions for the treatment of disease. New treatment alternatives will be introduced in the upcoming years because of the recent acceleration of research and development activity. For example, in May 2021, Takeda Pharmaceutical Company Limited announced that research and development for narcolepsy medication.

Narcolepsy Therapeutics Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.34% over the forecast period (2023-2030)
  • Based on Type segmentation, cataplexy segment was predicted to show maximum market share in the year 2022, owing to its high adoption of novel drugs such as WAKIX, Xyrem, Xywav, etc.
  • Based on Product segmentation, sodium oxybate was the leading segment in 2022, mainly due to growing awareness levels pertaining to diagnosis.
  • On the basis of region, North America was the leading revenue generator in 2022. Asia Pacific expected to grow at the fastest CAGE over the forecast period.

Narcolepsy Therapeutics Market- Segmentation Analysis:

The Global Narcolepsy Therapeutics Market is segmented on the basis of Type, Product, and Region.

The market is divided into two categories based on Type: cataplexy and without cataplexy. The cataplexy segment dominates the market. The rise in a prevalence of cataplexy as a major symptom in patients is boosting the segment growth.

The market is divided into three categories based on Product: Central Nervous System Stimulants, Sodium Oxybate, and Tricyclic Antidepressants. The Sodium Oxybate segment dominates the market and is likely to maintain its dominance during the forecast period. It is anticipated that rising R&D efforts pertaining to CNS stimulants for patients with uncommon neurological illnesses will drive the segment's growth.

Narcolepsy Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Narcolepsy Therapeutics Market- Competitive Landscape:

The Narcolepsy Therapeutics market is less fragmented in nature with few players dominating global market. Key players in the market are focused on new product design paired with the rapid investment and mergers & acquisitions. For example, in May 2022, Axsome Therapeutics, Inc. announced the attainment of Sunosi from Jazz Pharmaceuticals across U.S. market.

Recent Developments:

In May 2023, Avadel Pharmaceuticals received final U.S. FDA approval for its drug Lumryz for the treatment of narcolepsy.

In January 2022, the U.S. FDA approved Orphan Drug Exclusivity for Jazz Pharmaceuticals' Xywav for the treatment of idiopathic hypersomnia in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NARCOLEPSY THERAPEUTICS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • Avadel Pharmaceuticals
  • Jazz Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company
  • Harmony Biosciences
  • Novartis AG
  • Rhodes Pharmaceuticals L.P.
  • Axsome Therapeutics, Inc.
  • Janssen Global Services, LLC
  • Ligand Pharmaceuticals Incorporated
  • Shionogi Inc.
  • Eli Lilly and Company
  • Others

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY TYPE

  • Cataplexy
  • Without Cataplexy

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY PRODUCT

  • Central Nervous System Stimulants
  • Sodium Oxybate
  • Tricyclic Antidepressants

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Narcolepsy Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Narcolepsy Therapeutics Market Snippet by Type
    • 2.1.2. Narcolepsy Therapeutics Market Snippet by Product
    • 2.1.3. Narcolepsy Therapeutics Market Snippet by Country
    • 2.1.4. Narcolepsy Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Narcolepsy Therapeutics Key Market Trends

  • 3.1. Narcolepsy Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Narcolepsy Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Narcolepsy Therapeutics Market Opportunities
  • 3.4. Narcolepsy Therapeutics Market Future Trends

4. Narcolepsy Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Narcolepsy Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Narcolepsy Therapeutics Market Landscape

  • 6.1. Narcolepsy Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Narcolepsy Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Cataplexy
    • 7.1.3. Without Cataplexy

8. Narcolepsy Therapeutics Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Central Nervous System Stimulants
    • 8.1.3. Sodium Oxybate
    • 8.1.4. Tricyclic Antidepressants.

9. Narcolepsy Therapeutics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Narcolepsy Therapeutics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Narcolepsy Therapeutics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.7.5. Overview
      • 9.3.7.6. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.7. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.8. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.8. France
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.8.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.9. Russia
      • 9.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.10. Netherlands
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.11. Sweden
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.12. Poland
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.13. Rest of Europe
      • 9.3.13.1. Overview
      • 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Narcolepsy Therapeutics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.6.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Narcolepsy Therapeutics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.6.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Narcolepsy Therapeutics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.6.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Narcolepsy Therapeutics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Teva Pharmaceutical Industries Ltd.
    • 10.2.2. Avadel Pharmaceuticals
    • 10.2.3. Jazz Pharmaceuticals, Inc.
    • 10.2.4. Takeda Pharmaceutical Company
    • 10.2.5. Harmony Biosciences
    • 10.2.6. Novartis AG
    • 10.2.7. Rhodes Pharmaceuticals L.P.
    • 10.2.8. Axsome Therapeutics, Inc.
    • 10.2.9. Janssen Global Services, LLC
    • 10.2.10. Ligand Pharmaceuticals Incorporated
    • 10.2.11. Shionogi Inc.
    • 10.2.12. Eli Lilly and Company
    • 10.2.13. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Narcolepsy Therapeutics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Narcolepsy Therapeutics Market, by Type 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Narcolepsy Therapeutics Market, by Product 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Narcolepsy Therapeutics Market, by End-User 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Narcolepsy Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)